|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | |||||||||
| Short-term marketable securities | |||||||||
| Prepaid expenses and other current assets | |||||||||
| Total current assets | |||||||||
| Prepaid expenses and other assets, non-current | |||||||||
| Operating lease right-of-use asset | |||||||||
| Property, plant and equipment, net | |||||||||
| Restricted cash | |||||||||
| Total assets | |||||||||
| Liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) | |||||||||
| Current liabilities | |||||||||
| Accounts payable | |||||||||
| Accrued research and development expenses | |||||||||
| Accrued compensation and other current liabilities | |||||||||
| Accrued restructuring liabilities | |||||||||
| Severance liability | |||||||||
| Total current liabilities | |||||||||
| Derivative tranche liability | |||||||||
| Operating lease liability, non-current | |||||||||
| Severance liability, non-current | |||||||||
| Total liabilities | |||||||||
| Redeemable convertible preferred shares, no par value; no shares authorized, issued and outstanding as of December 31, 2023; 104,461,636 shares authorized as of December 31, 2022, par value of $0.00001 per share; 40,743,522 shares issued and outstanding as of December 31, 2022; aggregate liquidation preference $408,000 as of December 31, 2022 | |||||||||
| Stockholders’ equity (deficit) | |||||||||
| Preferred stock, 10,000,000 shares authorized, $0.00001 par value, no shares issued and outstanding at December 31, 2023; no shares authorized, issued, and outstanding at December 31, 2022 | |||||||||
| Common stock, par value of $0.00001 per share; 790,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 100,907,206 and 100,452,061 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated other comprehensive income (loss) income | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity (deficit) | |||||||||
| Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit) |
Loading...
